AGL (Agilon Health, Inc.) — Stock Analysis, Catalysts & AI Research

Agilon Health, Inc.

$113.15

The Read: Agilon Health’s stock surged dramatically—over 170% to 2400%—after CMS’s favorable 2027 Medicare Advantage rates and strong Q1 2026 earnings beat with raised guidance and operational progress, reflecting investor confidence in improved Medicare reimbursement and cost management.

Price

Overlays

Panel

AGL

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Agilon Health, Inc.

$113.15

Health CareMedical - Care Facilities

Price

Overlays

Panel

AGL

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Create your free account to unlock active Expected Moves for AGL

Expected Moves

Agilon Health, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Create your free account to unlock active Expected Moves for AGL

Expected Moves

Agilon Health, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow